Concepedia

Sam Cross-Knorr

SC

Statistics

Publications

4

Citations

176

H-Index

4

Active since

2012

Affiliations

Rhode Island Hospital(Current)

Brown University

Providence College

Sam Cross-Knorr is an author at Rhode Island Hospital specializing in oncology, cancer cell signaling, and oncogenic signaling pathways.

Publications per year

2012–2014

4

Publications

4

RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients

Sam Cross-Knorr, Shaolei Lu, Kimberly Perez et al. · BMC Cancer · 2013 · 58 citations · Full text

Medicine, Oncology, Pharmacology +17

Raf Kinase Inhibitor Protein (RKIP) Blocks Signal Transducer and Activator of Transcription 3 (STAT3) Activation in Breast and Prostate Cancer

Saad Yousuf, Meili Duan, Erika L. Moen et al. · PLoS ONE · 2014 · 57 citations · Full text

Medicine, Oncology, Cell Signaling +10

Reversal of chemosensitivity and induction of cell malignancy of a non-malignant prostate cancer cell line upon extracellular vesicle exposure

Kiriaki Panagopoulos, Sam Cross-Knorr, Christen Dillard et al. · Molecular Cancer · 2013 · 41 citations · Full text

Life Sciences, Cell Biology, Oncology +16

Regulation of RKIP Function by Helicobacter pylori in Gastric Cancer

Erika L. Moen, Sicheng Wen, Talha Anwar et al. · PLoS ONE · 2012 · 20 citations · Full text

Life Sciences, Oncology, Apoptosis +15

1–4 of 4